These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 20818715)

  • 1. [Effects of the mobilization with AMD3100, granulocyte-colony-stimulating factor (G-CSF) alone and in combination on the immunological function of the lymphocytes in mice].
    Kong Y; Feng R; Huang XJ
    Zhonghua Xue Ye Xue Za Zhi; 2012 May; 33(5):358-61. PubMed ID: 22781791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mobilization of hematopoietic stem cells with the novel CXCR4 antagonist POL6326 (balixafortide) in healthy volunteers-results of a dose escalation trial.
    Karpova D; Bräuninger S; Wiercinska E; Krämer A; Stock B; Graff J; Martin H; Wach A; Escot C; Douglas G; Romagnoli B; Chevalier E; Dembowski K; Hooftman L; Bonig H
    J Transl Med; 2017 Jan; 15(1):2. PubMed ID: 28049490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single-dose MGTA-145/plerixafor leads to efficient mobilization and in vivo transduction of HSCs with thalassemia correction in mice.
    Li C; Goncalves KA; Raskó T; Pande A; Gil S; Liu Z; Izsvák Z; Papayannopoulou T; Davis JC; Kiem HP; Lieber A
    Blood Adv; 2021 Mar; 5(5):1239-1249. PubMed ID: 33646305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A phase III randomized crossover trial of plerixafor versus G-CSF for treatment of WHIM syndrome.
    McDermott DH; Velez D; Cho E; Cowen EW; DiGiovanna JJ; Pastrana DV; Buck CB; Calvo KR; Gardner PJ; Rosenzweig SD; Stratton P; Merideth MA; Kim HJ; Brewer C; Katz JD; Kuhns DB; Malech HL; Follmann D; Fay MP; Murphy PM
    J Clin Invest; 2023 Oct; 133(19):. PubMed ID: 37561579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective Comparative Study of Etoposide plus G-CSF versus G-CSF Alone, Followed by Risk-Adapted Plerixafor for Peripheral Blood Stem Cell Mobilization in Patients with Newly Diagnosed Multiple Myeloma: CAtholic REsearch Network for Multiple Myeloma Study (CAREMM-2001).
    Park SS; Shin SH; Lee JY; Jeon YW; Yhang SA; Min CK
    Cancers (Basel); 2023 Sep; 15(19):. PubMed ID: 37835477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cryopreserved ECP-treated lymphocytes maintain apoptotic response and anti-proliferative effect.
    Radwanski K; Heber C; Min K
    J Clin Apher; 2015 Jun; 30(3):154-61. PubMed ID: 25213780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Harvesting autologous stem cells from a patient with red blood cell abnormalities of β-thalassemia intermedia.
    Sanford K; Roseff SD; Anderson J; Chung HM; McPherson RA
    Transfusion; 2014 Jul; 54(7):1881-6. PubMed ID: 24527966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An international survey of pediatric apheresis practice.
    Delaney M; Capocelli KE; Eder AF; Schneiderman J; Schwartz J; Sloan SR; Wong EC; Kim HC
    J Clin Apher; 2014 Apr; 29(2):120-6. PubMed ID: 24105856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of therapeutic plasma exchange on coagulation parameters in patients on warfarin.
    Zantek ND; Morgan S; Zantek PF; Mair DC; Bowman RJ; Aysola A
    J Clin Apher; 2014 Apr; 29(2):75-82. PubMed ID: 24000079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relapses of thrombotic thrombocytopenic purpura after treatment with rituximab.
    Goyal J; Adamski J; Lima JL; Marques MB
    J Clin Apher; 2013 Dec; 28(6):390-4. PubMed ID: 23857472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequency of adverse events in plateletpheresis donors in regional transfusion centre in North India.
    Patidar GK; Sharma RR; Marwaha N
    Transfus Apher Sci; 2013 Oct; 49(2):244-8. PubMed ID: 23830186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The treatment of nephrogenic systemic fibrosis with therapeutic plasma exchange.
    Poisson JL; Low A; Park YA
    J Clin Apher; 2013 Aug; 28(4):317-20. PubMed ID: 23426620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analyses of data of patients with Thrombotic Microangiopathy in the WAA registry.
    Mörtzell M; Berlin G; Nilsson T; Axelsson CG; Efvergren M; Audzijoni J; Griskevicius A; Ptak J; Blaha M; Tomsova H; Liumbruno GM; Centoni P; Newman E; Eloot S; Dhondt A; Tomaz J; Witt V; Rock G; Stegmayr B
    Transfus Apher Sci; 2011 Oct; 45(2):125-31. PubMed ID: 21903476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD34⁺ collection efficiency as a function of blood volumes processed in pediatric autologous peripheral blood stem cell collection.
    Dubrovsky L; Wong EC; Perez-Albuerne E; Loechelt B; Kamani N; Sande J; Mintz K; Paul W; Luban NL; Rood BR; Fry T
    J Clin Apher; 2011; 26(3):131-7. PubMed ID: 21294153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calculations in apheresis.
    Neyrinck MM; Vrielink H;
    J Clin Apher; 2015 Feb; 30(1):38-42. PubMed ID: 25041907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plerixafor is superior to conventional chemotherapy for first-line stem cell mobilisation, and is effective even in heavily pretreated patients.
    Clark RE; Bell J; Clark JO; Braithwaite B; Vithanarachchi U; McGinnity N; Callaghan T; Francis S; Salim R
    Blood Cancer J; 2014 Oct; 4(10):e255. PubMed ID: 25360901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased mobilization and yield of stem cells using plerixafor in combination with granulocyte-colony stimulating factor for the treatment of non-Hodgkin's lymphoma and multiple myeloma.
    Pelus LM; Farag SS
    Stem Cells Cloning; 2011; 4():11-22. PubMed ID: 24198526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plerixafor: a review of its use in stem-cell mobilization in patients with lymphoma or multiple myeloma.
    Keating GM
    Drugs; 2011 Aug; 71(12):1623-47. PubMed ID: 21861545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plerixafor mobilization leads to a lower ratio of CD34+ cells to total nucleated cells which results in greater storage costs.
    Tanhehco YC; Adamski J; Sell M; Cunningham K; Eisenmann C; Magee D; Stadtmauer EA; O'Doherty U
    J Clin Apher; 2010; 25(4):202-8. PubMed ID: 20818715
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.